Envista Holdings (NVST) Net Income towards Common Stockholders (2018 - 2026)

Envista Holdings (NVST) recorded quarterly Net Income towards Common Stockholders of $38.7 million in Q2 2026, up 17.63% quarter-over-quarter from $32.9 million in Q4 2025, and up 115.0% on a YoY basis from $18.0 million in Q2 2025.

Envista Holdings (NVST) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

Envista Holdings' Net Income towards Common Stockholders history runs 8 years deep, the most recent figure standing at $38.7 million for Q2 2026.

  • In Q2 2026, Net Income towards Common Stockholders rose 115.0% year-over-year to $38.7 million; the TTM figure through Apr 2026 stood at $67.7 million (up 106.02% YoY), while the FY2025 annual figure was $47.0 million, changed N/A from the prior year.
  • Net Income towards Common Stockholders was $38.7 million for Q2 2026 at Envista Holdings, up from $32.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $38.7 million in Q2 2026 to a low of -$1.2 billion in Q2 2024.
  • Historically, Net Income towards Common Stockholders has averaged -$85.6 million across 4 years, with a median of $6.4 million in 2022.
  • Biggest YoY gain for Net Income towards Common Stockholders was 2641.67% in 2025; the steepest drop was 469.51% in 2025.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at -$2.0 million in 2022, then surged by 160.0% to $1.2 million in 2024, then jumped by 2641.67% to $32.9 million in 2025, then grew by 17.63% to $38.7 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $38.7 million (Q2 2026), $32.9 million (Q4 2025), and -$30.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 147.79 Bn 143.40 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.23 Bn 40.22 Bn 2.15 Bn -274.00 Mn
3 Medline 30.57 Bn 36.41 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.04 Bn 26.38 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.76 Bn 23.24 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.40 Bn 13.40 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.18 Bn 13.04 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.72 Bn 11.66 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.71 Bn 8.67 Bn 891.00 Mn 2.00 Mn
10 Envista Holdings 4.04 Bn 2.96 Bn 390.10 Mn 38.70 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 38.70 Mn
Dec 31, 2025 32.90 Mn
Sep 26, 2025 -30.30 Mn
Jun 27, 2025 26.40 Mn
Mar 28, 2025 18.00 Mn
Dec 31, 2024 1.20 Mn
Sep 27, 2024 8.20 Mn
Jun 28, 2024 -1.15 Bn
Mar 29, 2024 23.60 Mn
Sep 30, 2022 -2.00 Mn
Jul 1, 2022 2.60 Mn
Apr 1, 2022 4.50 Mn
Dec 31, 2021 43.30 Mn
Oct 1, 2021 12.70 Mn
Jul 2, 2021 11.10 Mn
Apr 2, 2021 9.90 Mn
Dec 31, 2020 17.30 Mn
Oct 2, 2020 12.00 Mn
Jul 3, 2020 -93.50 Mn
Apr 3, 2020 -17.20 Mn